Mikhail Varshavski, D.O., more widely known as Doctor Mike to his 29 million followers, noticed eight years ago the growing ...

James Potter, the executive director at Coalition for Healthcare Communication (CHC), has rose-colored glasses on. | In a ...

It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia ...

The resulting report, published this week ahead of Swoop’s presentation at the Fierce Pharma Week conference in Philadelphia, ...

As Robert F. Kennedy Jr.’s revamped CDC vaccine advisory panel gears up to meet next week, U.S. | As Robert F. Kennedy Jr.’s ...

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...

With Pfizer discontinuing Beqvez and BioMarin scaling back the commercial focus of Roctavian, the curative promise of ...

While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company this week triumphed over a whistleblower lawsuit | A ...

The changes come five weeks into the tenure of new CEO Maziar Mike Doustdar. Doustdar was tapped to replace Novo's previous ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the ...

Following CapVest Partners' takeover of Germany’s Stada earlier this month, another private equity group is looking to cash ...

The Trump administration is reportedly weighing an executive order to limit drug licensing deals with Chinese biotechs. | The ...